Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER

Tesamorelin Handling Guide: Common Mistakes to Avoid

Most handling advice for research peptides is written generically. The practices below are the ones that specifically matter for Tesamorelin — including the mistakes it is unusually easy to make with this compound.

Full-length 44-residue GHRH analogue with trans-3-hexenoic acid modificationHormonal & EndocrineMetabolic

In plain English

Allow several minutes for dissolving, swirl gently, never shake, and never freeze mixed solution. Patience is genuinely the main technique with this compound.

What Tesamorelin actually is

Tesamorelin keeps the body's own growth hormone-releasing signal completely intact — all forty-four amino acids — and adds one small chemical cap to the end. That cap exists for a single reason: an enzyme would otherwise destroy the natural molecule within minutes, and the cap blocks it from reaching its cutting point.

Supplied for laboratory research use only — not for human or animal use.

Research-grade Tesamorelin

Third-party tested by HPLC and LC-MS, ≥99% purity, with a Certificate of Analysis on every order. Ships across Canada.

Technical detail below

Bench practices for Tesamorelin

  • Allow several minutes for dissolution; do not accelerate with agitation or heat.
  • Swirl gently — long chains aggregate at interfaces.
  • Do not freeze reconstituted solution.

The chemistry behind these practices

  • Aggregation at air–liquid interfaces from agitation — the practical failure mode for longer chains.
  • Asparagine deamidation, of which a 44-residue sequence has multiple opportunities.
  • Methionine oxidation at susceptible positions.
  • Proteolysis in any biological matrix, though the N-terminal modification specifically blocks the DPP-4 route.

Storage summary

LyophilizedSealed at -20 °C. Longer chains generally have less thermal margin than short peptides; minimise ambient exposure.
ReconstitutedRefrigerate at 2–8 °C. Longer peptides have more potential degradation sites simply by virtue of length.

What Tesamorelin is studied for

GHRH receptor agonism

Full-length GHRH activity with DPP-4 resistance conferred by the N-terminal modification.

Visceral adipose tissue

The most distinctive endpoint in its research literature.

GH pulsatility

Studied for effects on endogenous GH secretion patterns rather than direct GH substitution.

Metabolic parameters

Investigated alongside body-composition endpoints in metabolic research.

Summarizes published preclinical literature. Provided for research reference only; not a claim of efficacy or a description of human use.

More Tesamorelin reference

Lab Handling reference for other compounds

Tesamorelin overview Tesamorelin calculatorTesamorelin product details

Tesamorelin is supplied strictly as a research chemical for in-vitro laboratory and research use only. It is not intended for human or animal consumption, diagnostic, or therapeutic use. This page is educational laboratory-handling reference information — not medical advice, not usage guidance, and not a protocol.